Chargement en cours...
Immune checkpoint pathways in non-small cell lung cancer
Immunotherapy has evolved at a phenomenal pace in cancer therapeutics. This has primarily been fueled by the much perceived necessity to procure an alternative to current standard of care chemotherapy agents, owing to several concerns such as treatment-related toxicity and poor long-term survival as...
Enregistré dans:
| Publié dans: | Ann Transl Med |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AME Publishing Company
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5890048/ https://ncbi.nlm.nih.gov/pubmed/29666811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.09.30 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|